| BRAF Mutations in Hairy-Cell Leukemia E Tiacci, V Trifonov, G Schiavoni, A Holmes, W Kern, MP Martelli, ... New England Journal of Medicine 364 (24), 2305-2315, 2011 | 1259 | 2011 |
| Early Interim 2-[18F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Is Prognostically Superior to International Prognostic Score in Advanced-Stage … A Gallamini, M Hutchings, L Rigacci, L Specht, F Merli, M Hansen, C Patti, ... Journal of clinical oncology 25 (24), 3746-3752, 2007 | 1052 | 2007 |
| The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease A Gallamini, L Rigacci, F Merli, L Nassi, A Bosi, I Capodanno, S Luminari, ... haematologica 91 (4), 475-481, 2006 | 375 | 2006 |
| Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis A Contri, AM Brunati, L Trentin, A Cabrelle, M Miorin, L Cesaro, LA Pinna, ... The Journal of clinical investigation 115 (2), 369-378, 2005 | 344 | 2005 |
| The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale A Gallamini, SF Barrington, A Biggi, S Chauvie, L Kostakoglu, ... Haematologica 99 (6), 1107, 2014 | 299 | 2014 |
| COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus L Scarfò, T Chatzikonstantinou, GM Rigolin, G Quaresmini, M Motta, ... Leukemia 34 (9), 2354-2363, 2020 | 286 | 2020 |
| Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact P Baliakas, S Jeromin, M Iskas, A Puiggros, K Plevova, F Nguyen-Khac, ... Blood, The Journal of the American Society of Hematology 133 (11), 1205-1216, 2019 | 264 | 2019 |
| Cxcr3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection C Agostini, F Calabrese, F Rea, M Facco, A Tosoni, M Loy, G Binotto, ... The American journal of pathology 158 (5), 1703-1711, 2001 | 264 | 2001 |
| Involvement of the IP-10 chemokine in sarcoid granulomatous reactions C Agostini, M Cassatella, R Zambello, L Trentin, S Gasperini, A Perin, ... The Journal of Immunology 161 (11), 6413-6420, 1998 | 237 | 1998 |
| Role of IL-15, IL-2, and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis. C Agostini, L Trentin, M Facco, R Sancetta, A Cerutti, C Tassinari, ... Journal of immunology (Baltimore, Md.: 1950) 157 (2), 910-918, 1996 | 217 | 1996 |
| The lymphoproliferative disease of granular lymphocytes. A heterogeneous disorder ranging from indolent to aggressive conditions G Semenzato, F Pandolfi, T Chisesi, G De Rossi, G Pizzolo, R Zambello, ... Cancer 60 (12), 2971-2978, 1987 | 217 | 1987 |
| Simple genetic diagnosis of hairy cell leukemia by sensitive detection of the BRAF-V600E mutation E Tiacci, G Schiavoni, F Forconi, A Santi, L Trentin, A Ambrosetti, ... Blood, The Journal of the American Society of Hematology 119 (1), 192-195, 2012 | 210 | 2012 |
| Early chemotherapy intensification with escalated BEACOPP in patients with advanced-stage Hodgkin lymphoma with a positive interim positron emission tomography/computed … A Gallamini, C Tarella, S Viviani, A Rossi, C Patti, A Mulé, M Picardi, ... Journal of Clinical Oncology 36 (5), 454-462, 2018 | 206 | 2018 |
| The chemokine receptor CXCR3 is expressed on malignant B cells and mediates chemotaxis L Trentin, C Agostini, M Facco, F Piazza, A Perin, M Siviero, C Gurrieri, ... The Journal of clinical investigation 104 (1), 115-121, 1999 | 206 | 1999 |
| Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomas L Trentin, A Cabrelle, M Facco, D Carollo, M Miorin, A Tosoni, P Pizzo, ... Blood 104 (2), 502-508, 2004 | 201 | 2004 |
| Fixed-duration ibrutinib plus venetoclax for first-line treatment of CLL: primary analysis of the CAPTIVATE FD cohort CS Tam, JN Allan, T Siddiqi, TJ Kipps, R Jacobs, S Opat, PM Barr, ... Blood, The Journal of the American Society of Hematology 139 (22), 3278-3289, 2022 | 176 | 2022 |
| Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations V Ljungström, D Cortese, E Young, T Pandzic, L Mansouri, K Plevova, ... Blood, The Journal of the American Society of Hematology 127 (8), 1007-1016, 2016 | 168 | 2016 |
| Direct pharmacological targeting of a mitochondrial ion channel selectively kills tumor cells in vivo L Leanza, M Romio, KA Becker, M Azzolini, L Trentin, A Manago, ... Cancer cell 31 (4), 516-531. e10, 2017 | 167 | 2017 |
| Bronchoalveolar lavage and lung histology: comparative analysis of inflammatory and immunocompetent cells in patients with sarcoidosis and hypersensitivity pneumonitis G Semenzato, M Chilosi, E Ossi, L Trentin, G Pizzolo, A Cipriani, ... American Review of Respiratory Disease 132 (2), 400-404, 1985 | 166 | 1985 |
| Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study P Baliakas, A Hadzidimitriou, LA Sutton, E Minga, A Agathangelidis, ... The lancet haematology 1 (2), e74-e84, 2014 | 160 | 2014 |
